Shotsy is a specialized medication tracker for GLP-1 weight loss and diabetes patients, providing dose scheduling and clinical-data visualizations on iOS.
Product velocity
Active
Daily rank 🇺🇸
#67
▼8Health & Fitness · grossing
Sentiment
4.8
23k reviews
Nemesis
Calorie Counter by Lose It!
The App DNA
What makes this app unique?
Users hire Shotsy to manage the complexity of multi-drug injection schedules and visualize medication levels, which standard calorie trackers fail to address.
For Individuals prescribed GLP-1 receptor agonists for weight management or type 2 diabetes requiring precise dose tracking.
Key features
Visualizes medication concentration over time using peer-reviewed clinical data.
Supports simultaneous tracking of multiple GLP-1 injections and daily oral pills.
Automates data import for weight, calories, protein, and water intake.
How much does it cost?
Transitioning from a free tool to a subscription model has created significant friction with long-term users.
Velocity
Active developmentUX improvementsperformancenew contentShow more...
The app is currently in an active development phase, shipping 5 releases over the last 74 days, averaging approximately 0.47 releases per week. Development is focused on iterative UX improvements and feature expansion, specifically regarding medication tracking and data visualization. The v3.0 release served as a significant milestone, introducing maintenance mode and enhanced scheduling, while subsequent updates have focused on stability and usability refinements. The development trend is stable, with a clear focus on feature-rich updates rather than purely maintenance-based patches.
Who built it?
User Sentiment
What do users think recently?
Review voice lately leans excited. Users appreciate estimated medication level charts provide actionable insights for managing injection schedules and symptoms, but report paywalling previously free features like medication level charts creates friction for long-term users.
How are ratings & reviews evolving?
What users say, by theme
- Estimated medication level charts provide actionable insights for managing injection schedules and symptoms
- Paywalling previously free features like medication level charts creates friction for long-term users
84 of 98 recent reviews analyzed · high confidence · Excited overall
Read the full review analysisUnlock 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Shotsy GLP-1 Tracker
How's the Health & Fitness market?
Shotsy holds a #80 Grossing rank in the US Health & Fitness category, with international growth evidenced by a #25 Grossing rank in Uruguay. The gap between its utility-driven retention and the recent subscription-gate friction suggests a need to re-align monetization with user value.
Read the market outlookThe rivals identified
By FitNow
Massive user base and high release velocity make this the primary generalist threat for weight loss tracking.
- Extensive food database with barcode scanning capabilities that Shotsy currently lacks for nutrition tracking.
- Advanced community features and social challenges that drive long-term user retention beyond simple logging.
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Shotsy GLP-1 Tracker
Where is it heading?
The GLP-1 tracking market is consolidating, with generalist apps adding specialized modules to compete with niche tools like Shotsy. The app's future depends on whether it can maintain its clinical-data moat while resolving the technical instability that currently undermines its premium positioning.
- Data loss incidents following the latest update erode trust, which directly increases churn risk for long-term users.
- High international grossing ranks in emerging markets suggest strong demand for the specialized medication-level visualization feature.
The SWOT
- Clinical-data visualization creates high switching costs
- Multi-medication scheduling addresses complex poly-pharmacy needs
- Integration of milestone photo tracking for progress
- Expansion into non-GLP-1 chronic medication tracking
Next best moves
Audit data persistence logic because data loss is a top-3 complaint → restore user trust
+ 1 more prioritized moveThe counter-intuitive read
The subscription-gate backlash is not a pricing problem but a value-perception failure…
Read the full takeFeature gaps
Barcode scanning (available in Lose It! but missing here) +1
Since the last report: The app shifted core features behind a subscription paywall, causing user friction and technical stability concerns despite an overall positive sentiment trend.
Bottom line
Shotsy holds a strong category lead through specialized clinical-data visualization, but the recent subscription-gate friction and data-loss incidents threaten long-term retention, so the PM must prioritize data reliability and re-tier the monetization model to prevent churn to free alternatives.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated